Competitive Landscape of the Cancer Gene Therapy Market 2022-2028

The Cancer Gene Therapy Market was estimated at US$ 1.23 billion in 2021 and is expected to grow at a CAGR of 18.3% during 2022-2028 to reach US$ ~11.9 billion in 2028.
In 2021, North America led the cancer gene therapy market due to strong R&D support, major market players, and collaborative efforts in developing gene therapies.